16:39 EDT PTC Therapeutics sees FY23 revenue $940M-$1.0B, consensus $938.32M
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on PTCT:
- PTC Therapeutics Provides Corporate Update and Reports Third Quarter Financial Results
- PTC Therapeutics signs royalty agreement with Royalty Pharma for Evrysdi
- PTC Therapeutics Announces Evrysdi® Royalty Agreement with Royalty Pharma for Up To $1.5 Billion
- e.l.f. Beauty upgraded, AutoZone downgraded: Wall Street’s top analyst calls
- PTC Therapeutics cut to Hold at Truist on financing and development hurdles